Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non‐small cell lung cancer

Immune checkpoint inhibitors (ICIs) have shown promising efficacy in the treatment of non‐small cell lung cancer (NSCLC). Sex‐associated dimorphism in immune system response is acknowledged, but the effect of patients’ sex on efficacy of ICIs as treatment in NSCLC still remains controversial. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chengdi, Qiao, Wenliang, Jiang, Yuting, Zhu, Min, Shao, Jun, Ren, Pengwei, Liu, Dan, Li, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639192/
https://www.ncbi.nlm.nih.gov/pubmed/31165589
http://dx.doi.org/10.1002/cam4.2280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639192/
https://www.ncbi.nlm.nih.gov/pubmed/31165589
http://dx.doi.org/10.1002/cam4.2280

Ejemplares similares